Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 93,041 $ 41,920
Short-term investments   6,494
Prepaid expenses and other current assets 5,165 3,988
Total current assets 98,206 52,402
Other assets 573 812
Deferred offering costs 187 70
Restricted cash 273 273
Property and equipment, net 298 405
Operating lease right-of-use asset (Note 8) 2,999 3,191
Total assets 102,536 57,153
Current liabilities:    
Accounts payable 4,639 7,177
Accrued expenses 4,141 3,801
Warrant liabilities 17,564  
Operating lease liability, current portion (Note 8) 52 36
Total current liabilities 26,396 11,014
Warrant liabilities 33,592 18,396
Convertible debt and derivative liabilities (Note 7) 16,516 11,522
Operating lease liability (Note 8) 3,274 3,326
Total liabilities 79,778 44,258
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, authorized 5,000,000 shares as of December 31, 2020 and December 31, 2019; 0 shares issued and outstanding as of December 31, 2020 and December 31, 2019 0 0
Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2020, and December 31, 2019; 19,663,698 and 9,741,372 shares issued and outstanding as of December 31, 2020, and December 31, 2019, respectively 20 10
Additional paid-in capital 349,351 284,313
Accumulated deficit (326,613) (271,428)
Total stockholders’ equity 22,758 12,895
Total liabilities and stockholders’ equity $ 102,536 $ 57,153